GGrantIndex
← Leaderboards

Scott Charles Baraban

University Of California, San Francisco

$24,650,943
Attributed
$26,852,292
Total exposure
13
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY200525
$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$26,852,292 · 13

By mechanism

R01$20,884,357 · 9
R37$4,368,667 · 1
R21$1,599,268 · 3

Top collaborators

Most similar at University Of California, San Francisco

Same institution · by research overlap

Others in their field

Top investigators on “Epilepsy

Research focus

EpilepsySeizuresPhenotypeBrainBenchmarkingNational Institute Of Neurological Disorders And StrokeGeneticBaseExhibitsLaboratoriesZebrafishGenerationsNeuronsBehavioralDesignCellsElectrophysiology (Science)BehaviorIn VivoIn VitroImageMutantResearch StudyNervous System Disorder

Grant awards (74)

An Interneuron-based Cell Therapy for Epilepsy$643,051
R01 · FY2025 · NS · contact PI
Deep Behavioral Phenotyping of Novel Zebrafish Epilepsy Models$69,700
R21 · FY2025 · NS · contact PI
An Interneuron-based Cell Therapy for Epilepsy$624,741
R01 · FY2024 · NS · contact PI
ZEBRAFISH MODELS FOR DRAVET SYNDROME RESEARCH AND DISCOVERY$494,954
R01 · FY2024 · NS · contact PI
Deep Behavioral Phenotyping of Novel Zebrafish Epilepsy Models$451,000
R21 · FY2024 · NS · contact PI
Gluconeogenic control of Dravet Syndrome$446,692
R01 · FY2024 · HD
An Interneuron-based Cell Therapy for Epilepsy$645,052
R01 · FY2023 · NS · contact PI
ZEBRAFISH MODELS FOR DRAVET SYNDROME RESEARCH AND DISCOVERY$510,261
R01 · FY2023 · NS · contact PI
Gluconeogenic control of Dravet Syndrome$457,317
R01 · FY2023 · HD
An Interneuron-based Cell Therapy for Epilepsy$676,758
R01 · FY2022 · NS · contact PI
ZEBRAFISH MODELS FOR DRAVET SYNDROME RESEARCH AND DISCOVERY$510,261
R01 · FY2022 · NS · contact PI
Gluconeogenic control of Dravet Syndrome$463,223
R01 · FY2022 · HD
Gluconeogenic control of Dravet Syndrome$158,867
R01 · FY2022 · HD
An Interneuron-based Cell Therapy for Epilepsy$676,609
R37 · FY2021 · NS · contact PI
ZEBRAFISH MODELS FOR DRAVET SYNDROME RESEARCH AND DISCOVERY$510,261
R01 · FY2021 · NS · contact PI
Gluconeogenic control of Dravet Syndrome$468,789
R01 · FY2021 · HD
An Interneuron-based Cell Therapy for Epilepsy$676,260
R37 · FY2020 · NS · contact PI
Gluconeogenic control of Dravet Syndrome$504,392
R01 · FY2020 · HD
ZEBRAFISH MODELS FOR DRAVET SYNDROME RESEARCH AND DISCOVERY$485,753
R01 · FY2020 · NS · contact PI
Functional evaluation of catastrophic childhood epilepsy genes in zebrafish$346,719
R01 · FY2020 · NS · contact PI
An Interneuron-based Cell Therapy for Epilepsy$644,947
R37 · FY2019 · NS · contact PI
Functional evaluation of catastrophic childhood epilepsy genes in zebrafish$346,719
R01 · FY2019 · NS · contact PI
Zebrafish models for Dravet syndrome research and discovery$346,719
R01 · FY2019 · NS · contact PI
An Interneuron-based Cell Therapy for Epilepsy$592,733
R37 · FY2018 · NS · contact PI
Functional evaluation of catastrophic childhood epilepsy genes in zebrafish$346,719
R01 · FY2018 · NS · contact PI
Zebrafish models for Dravet syndrome research and discovery$346,719
R01 · FY2018 · NS · contact PI
Functional evaluation of catastrophic childhood epilepsy genes in zebrafish$19,080
R01 · FY2018 · NS · contact PI
CRCNS: Quantitation of Network Dysfunction in Epilepsy-Understanding the Inhibitory Restraint$1
R01 · FY2018 · NS
An Interneuron-based Cell Therapy for Epilepsy$591,373
R37 · FY2017 · NS · contact PI
Functional evaluation of catastrophic childhood epilepsy genes in zebrafish$346,719
R01 · FY2017 · NS · contact PI
Zebrafish models for Dravet syndrome research and discovery$346,719
R01 · FY2017 · NS · contact PI
CRCNS: Quantitation of Network Dysfunction in Epilepsy-Understanding the Inhibitory Restraint$316,919
R01 · FY2017 · NS
An Interneuron-based Cell Therapy for Epilepsy$590,267
R37 · FY2016 · NS · contact PI
Zebrafish models for Dravet syndrome research and discovery$346,719
R01 · FY2016 · NS · contact PI
CRCNS: Quantitation of Network Dysfunction in Epilepsy-Understanding the Inhibitory Restraint$319,557
R01 · FY2016 · NS
An Interneuron-based Cell Therapy for Epilepsy$596,478
R37 · FY2015 · NS · contact PI
Using Zebrafish to Advance our Understanding and Treatment of Epilepsy$309,000
R01 · FY2015 · NS · contact PI
CRCNS: Quantitation of Network Dysfunction in Epilepsy-Understanding the Inhibitory Restraint$301,082
R01 · FY2015 · NS
An Interneuron-based Cell Therapy for Epilepsy$370,460
R01 · FY2014 · NS · contact PI
CRCNS: Quantitation of Network Dysfunction in Epilepsy-Understanding the Inhibitory Restraint$331,386
R01 · FY2014 · NS
Using Zebrafish to Advance our Understanding and Treatment of Epilepsy$305,910
R01 · FY2014 · NS · contact PI
An Interneuron-based Cell Therapy for Epilepsy$361,107
R01 · FY2013 · NS · contact PI
Epileptogenesis in the Malformed Brain$319,617
R01 · FY2013 · NS · contact PI
Using Zebrafish to Advance our Understanding and Treatment of Epilepsy$298,185
R01 · FY2013 · NS · contact PI
Using Zebrafish to Advance our Understanding and Treatment of Epilepsy$35,854
R01 · FY2013 · NS · contact PI
An Interneuron-based Cell Therapy for Epilepsy$374,203
R01 · FY2012 · NS · contact PI
Epileptogenesis in the Malformed Brain$331,209
R01 · FY2012 · NS · contact PI
Using Zebrafish to Advance our Understanding and Treatment of Epilepsy$293,386
R01 · FY2012 · NS · contact PI
An Interneuron-based Cell Therapy for Epilepsy$374,199
R01 · FY2011 · NS · contact PI
Epileptogenesis in the Malformed Brain$331,209
R01 · FY2011 · NS · contact PI
Interneurons and Epilepsy in Dlx1 Mutant Mice$227,115
R21 · FY2011 · NS · contact PI
An Interneuron-based Cell Therapy for Epilepsy$387,703
R01 · FY2010 · NS · contact PI
Epileptogenesis in the Malformed Brain$326,047
R01 · FY2010 · NS · contact PI
Interneurons and Epilepsy in Dlx1 Mutant Mice$193,125
R21 · FY2010 · NS · contact PI
Seizure resistance in zebrafish$299,568
R01 · FY2009 · NS · contact PI
Epileptogenesis in the Malformed Brain$255,774
R01 · FY2009 · NS · contact PI
MGE Progenitor Cell Grafts and Epilepsy$386,022
R01 · FY2008 · NS · contact PI
Seizure resistance in zebrafish$299,309
R01 · FY2008 · NS · contact PI
Epileptogenesis in the Malformed Brain$255,912
R01 · FY2008 · NS · contact PI
MGE Progenitor Cell Grafts and Epilepsy$449,269
R01 · FY2007 · NS · contact PI
Seizure resistance in zebrafish$298,494
R01 · FY2007 · NS · contact PI
Epileptogenesis in the Malformed Brain$255,300
R01 · FY2007 · NS · contact PI
MGE Progenitor Cell Grafts and Epilepsy$375,776
R01 · FY2006 · NS · contact PI
Epileptogenesis in the Malformed Brain$262,288
R01 · FY2006 · NS · contact PI
MGE Progenitor Cell Grafts and Epilepsy$57,562
R01 · FY2006 · NS · contact PI
MGE Progenitor Cell Grafts and Epilepsy$390,720
R01 · FY2005 · NS
MGE Progenitor Cell Grafts and Epilepsy$50,000
R01 · FY2005 · NS
Epileptogenesis in the Malformed Brain$295,000
R01 · FY2004 · NS
Genetics of Seizure Resistance: A Mutagenesis Strategy$220,433
R21 · FY2004 · NS
Epileptogenesis in the Malformed Brain$295,000
R01 · FY2003 · NS
Genetics of Seizure Resistance: A Mutagenesis Strategy$219,827
R21 · FY2003 · NS
Epileptogenesis in the Malformed Brain$295,000
R01 · FY2002 · NS
Genetics of Seizure Resistance: A Mutagenesis Strategy$218,068
R21 · FY2002 · NS
Epileptogenesis in the Malformed Brain$283,125
R01 · FY2001 · NS